Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118757845 | 11875784 | 5 | F | 201512 | 20160803 | 20151229 | 20160808 | EXP | JP-GLAXOSMITHKLINE-JP2015JPN175265 | GLAXOSMITHKLINE | 88.01 | YR | M | Y | 44.00000 | KG | 20160808 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118757845 | 11875784 | 1 | PS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000 MG, TID | Y | 20487 | 1000 | MG | TABLET | TID | |||||
| 118757845 | 11875784 | 2 | SS | ACICLOVIR | ACYCLOVIR | 1 | Intravenous drip | 500 MG, 1D | Y | 0 | 500 | MG | QD | ||||||
| 118757845 | 11875784 | 3 | SS | ACICLOVIR | ACYCLOVIR | 1 | Y | 0 | |||||||||||
| 118757845 | 11875784 | 4 | SS | ACICLOVIR | ACYCLOVIR | 1 | Y | 0 | |||||||||||
| 118757845 | 11875784 | 5 | C | LYRICA | PREGABALIN | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 6 | C | METHYCOBAL | METHYLCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 8 | C | CANDESARTAN CILEXETIL. | CANDESARTAN CILEXETIL | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 9 | C | LENDORMIN | BROTIZOLAM | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 10 | C | LANSOPRAZOLE-OD | LANSOPRAZOLE | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 11 | C | MAGMITT | MAGNESIUM OXIDE | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 12 | C | AZUNOL OINTMENT | 2 | UNK | 0 | ||||||||||||
| 118757845 | 11875784 | 13 | C | CHINESE MEDICINE | UNSPECIFIED INGREDIENT | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 14 | C | MOHRUS TAPE | KETOPROFEN | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 15 | C | ZEPELIN OPHTHALMIC SOLUTION | 2 | UNK | 0 | ||||||||||||
| 118757845 | 11875784 | 16 | C | FLUOROMETHOLONE. | FLUOROMETHOLONE | 1 | UNK | 0 | |||||||||||
| 118757845 | 11875784 | 17 | C | LAXOBERON SOLUTION | 2 | UNK | 0 | ||||||||||||
| 118757845 | 11875784 | 18 | C | AMITIZA | LUBIPROSTONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118757845 | 11875784 | 1 | Herpes zoster |
| 118757845 | 11875784 | 2 | Herpes zoster |
| 118757845 | 11875784 | 3 | Meningitis viral |
| 118757845 | 11875784 | 4 | Encephalopathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118757845 | 11875784 | OT |
| 118757845 | 11875784 | LT |
| 118757845 | 11875784 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118757845 | 11875784 | Acute kidney injury | |
| 118757845 | 11875784 | Altered state of consciousness | |
| 118757845 | 11875784 | Anger | |
| 118757845 | 11875784 | Decreased appetite | |
| 118757845 | 11875784 | Depressed level of consciousness | |
| 118757845 | 11875784 | Haematemesis | |
| 118757845 | 11875784 | Hypophagia | |
| 118757845 | 11875784 | Hyporesponsive to stimuli | |
| 118757845 | 11875784 | Memory impairment | |
| 118757845 | 11875784 | Myoclonus | |
| 118757845 | 11875784 | Renal impairment | |
| 118757845 | 11875784 | Toxic encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118757845 | 11875784 | 1 | 20151130 | 20151206 | 0 | |
| 118757845 | 11875784 | 2 | 20151207 | 20151209 | 0 |